Sunil Healthcare (NSE:SUNLOC) 9-Day RSI: N/A (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNLOC Sunil Healthcare Ltd NSE:SUNLOC
48 GF Score
Price ₹68.00
GF Value ₹66.99
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-21), Sunil Healthcare's 9-Day RSI is N/A.

The industry rank for Sunil Healthcare's 9-Day RSI or its related term are showing as below:

NSE:SUNLOC's 9-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 52.53
* Ranked among companies with meaningful 9-Day RSI only.

Sunil Healthcare  (NSE:SUNLOC) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Sunil Healthcare 9-Day RSI Related Terms


NSE:SUNLOC vs : 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunil Healthcare 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Sunil Healthcare's 9-Day RSI falls into.


NSE:SUNLOC
48GF Score
Sunil Healthcare Ltd NSE:SUNLOC
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare  (NSE:SUNLOC) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Sunil Healthcare (NSE:SUNLOC) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued. The current stock price of ₹68.00 is trading 1.5% above its estimated GF Value™ of ₹66.99. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for NSE:SUNLOC:

  • 9-Day RSI: N/A
  • GF Value™: ₹66.99 vs. price of ₹68.00 (1.5% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the NSE:SUNLOC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunil Healthcare Business Description

Comparable Companies
Other Exchanges 537253:India
Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
48GF Score

Get the complete analysis for NSE:SUNLOC

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price
₹66.99
GF Value